Pathobiology and evolving therapies of coronary artery vasospasm
Sign Up to like & getrecommendations! Published in 2021 at "Baylor University Medical Center Proceedings"
DOI: 10.1080/08998280.2021.1898907
Abstract: Abstract Coronary artery vasospasm is a known cause of chest pain and requires a high level of clinical suspicion for diagnosis. It also remains in the differential diagnosis for patients presenting with type 2 myocardial… read more here.
Keywords: artery vasospasm; evolving therapies; pathobiology evolving; coronary artery ... See more keywords
Evolving therapies in advanced oesophago-gastric cancers and the increasing role of immunotherapy
Sign Up to like & getrecommendations! Published in 2020 at "Expert Review of Anticancer Therapy"
DOI: 10.1080/14737140.2021.1866548
Abstract: ABSTRACT Introduction Esophagogastric cancers remain a considerable health burden and among the top causes of global cancer-related deaths. Chemotherapy remains the cornerstone of treatment for patients with advanced disease. Doublet platinum/fluoropyrimidine therapy is established as… read more here.
Keywords: gastric cancers; oesophago gastric; treatment; therapies advanced ... See more keywords
Evolving therapies for Fuchs' endothelial dystrophy.
Sign Up to like & getrecommendations! Published in 2018 at "Regenerative medicine"
DOI: 10.2217/rme-2017-0081
Abstract: Fuchs' endothelial dystrophy (FED) is characterized by corneal endothelial dysfunction and guttate excrescences on the posterior corneal surface, and is the leading indication for corneal transplantation in developed countries. In severe cases, keratoplasty is considered… read more here.
Keywords: therapies fuchs; medicine; fuchs endothelial; evolving therapies ... See more keywords